MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Voigt, J. M.
Right arrow Articles by Baron, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Voigt, J. M.
Right arrow Articles by Baron, J.

In situ localization and distribution of xenobiotic-activating enzymes and aryl hydrocarbon hydroxylase activity in lungs of untreated rats

JM Voigt, TT Kawabata, JP Burke, MV Martin, FP Guengerich and J Baron

Department of Pharmacology, University of Iowa, Iowa City 52242.

The present investigation was undertaken to more precisely establish where xenobiotics can be oxidatively metabolized and bioactivated within the lung. To accomplish this, antibodies raised against NADPH- cytochrome P-450 reductase (EC 1.6.2.4) and cytochromes P-450 BNF-B, PB- B, and PCN-E (the major forms of cytochrome P-450 induced by beta- naphthoflavone, phenobarbital, and pregnenolone-16 alpha-carbonitrile, respectively) that had been purified to apparent homogeneity from rat liver microsomes were used to determine the localizations and distributions of these enzymes immunohistochemically at the light microscopic level within lungs of untreated rats. Additionally, the intrapulmonary sites at which benzo(alpha)pyrene undergoes hydroxylation were identified in situ by means of fluorescence histochemistry. Immunohistochemical staining for NADPH-cytochrome P-450 reductase and cytochromes P-450 BNF-B, PB-B, and PCN-E was detected in bronchial epithelial cells, both ciliated and nonciliated (Clara) bronchiolar epithelial cells, and type II pneumocytes as well as other cells in the alveolar wall. Results of microfluorometric analyses of the immunofluorescence staining intensities of bronchial epithelial cells, Clara cells, and type II pneumocytes demonstrated further that Clara cells bound the antibodies raised to NADPH-cytochrome P-450 reductase and cytochrome P-450 PB-B to significantly greater extents than did bronchial epithelial cells and type II pneumocytes. Thus, in lungs of untreated rats, Clara cells contain the greatest amounts of these two enzymes. In marked contrast, the antibodies directed against cytochromes P-450 BNF-B and PCN-E were each bound to similar extents by bronchial epithelial cells, Clara cells, and type II pneumocytes. In agreement with immunohistochemical observations on the intrapulmonary localizations of NADPH-cytochrome P-450 reductase and cytochromes P-450 BNF-B, PB-B, and PCN-E in untreated rats, benzo(alpha)pyrene was hydroxylated in situ by bronchial and bronchiolar epithelial cells and alveolar wall cells, especially type II pneumocytes. These immunohistochemical and histochemical findings, thus, demonstrate that bronchial epithelial cells, Clara and ciliated bronchiolar epithelial cells, and type II pneumocytes as well as other alveolar wall cells represent sites for the in vivo oxidative metabolism and bioactivation of xenobiotics in lungs of untreated rats.

Volume 37, Issue 2, pp. 182-191, 02/01/1990
Copyright © 1990 by American Society for Pharmacology and Experimental Therapeutics




This article has been cited by other articles:


Home page
Drug Metab. Dispos.Home page
J. Borlak, M. Blickwede, T. Hansen, W. Koch, M. Walles, and K. Levsen
METABOLISM OF VERAPAMIL IN CULTURES OF RAT ALVEOLAR EPITHELIAL CELLS AND PHARMACOKINETICS AFTER ADMINISTRATION BY INTRAVENOUS AND INHALATION ROUTES
Drug Metab. Dispos., August 1, 2005; 33(8): 1108 - 1114.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
C. Lee, K. C. Watt, A.-M. Chang, C. G. Plopper, A. R. Buckpitt, and K. E. Pinkerton
Site-Selective Differences in Cytochrome P450 Isoform Activities. Comparison of Expression in Rat and Rhesus Monkey Lung and Induction in Rats
Drug Metab. Dispos., May 1, 1998; 26(5): 396 - 400.
[Abstract] [Full Text]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1990 by the American Society for Pharmacology and Experimental Therapeutics